Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Danish MS Society | UNKNOWN |
Not provided
Not provided
Not provided
The goal of the present study is to evaluate the effects of a dance-based concept entitled MS Ballroom Fitness (developed in Denmark by PT Elisabeth Dalsgaard) in persons with multiple sclerosis (pwMS). A total of 88 pwMS will be enrolled and equally randomized into an intervention group or a control-waitlist group. Those in the intervention group will undertake 7 weeks of MS Ballroom Fitness, with 2 sessions per week.
The investigators assume that balance, walking capacity as well as well-being will be improved.
Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system (CNS) causing demyelination of axons within the CNS as well as loss of axons and neurons. While a wide range of symptoms potentially develops due to the pathology of MS, lower extremity motor function appears preferentially affected. It is therefore not surprising that substantial impairments in balance and walking capacity have been reported in pwMS, based on both subjective (patient perspectives) and objective assessments. This is problematic as balance and walking capacity are rated among the most important bodily functions, and furthermore associated with mental well-being and quality of life.
In pwMS, walking balance/coordination can be assessed by the six spot step test (SSST). Dynamic balance/coordination can be assessed by the four sqaure step test (FSST). Balance can also be assessed by the functional reach test (FRT) as well as the 30-second single leg stance test. Other measures of walking capacity can be assessed by a 'simple' short distance walk test (e.g., the timed 25 foot maximal walk test (T25FWT)) and a long distance 'endurance' walk test (e.g., the 6-minute maximal walk test (6MWT)). In addition to these, the 12-item MS Walking Scale (MSWS-12) are commonly used to assess the patient-reported impact of MS on different aspects of walking ability.
Different modalities of exercise therapy have been shown effective in counteracting the deterioration of balance and walking capacity observed in pwMS, with improvements reported across all the tests outlined above. Interestingly, dance (including mixed modalities with a predominant dance-based content) appear particularly potent in terms of targeting impairments in balance AND walking capacity. Whilst some pilot/exploratory studies involving pwMS exist, the summarized evidence appear sparse and contain three major limitations. First, the majority of pwMS studies are small exploratory non-controlled studies lacking sample size calculations. Second, none of the identified dance studies provide a personalized approach, i.e., by designing interventions that embrace the needs and physical functional level of each participant. Third, none of the identified dance studies have assessed whether dance-induced adaptations in balance and walking capacity are accompanied by - or even translates into - improvements in mental well-being and quality of life.
Physiotherapist Elisabeth Dalsgaard has developed a dance-based concept entitled MS Ballroom FitnessTM (abbreviated MSB-Fit) with a specific focus on joy of life and inclusion. It is specifically adapted to pwMS, having three difficulty levels that correspond to three overall disability categories (sitting, standing, and walking pwMS).
The study sample size was calculated based on unpublished SSST pilot data from n=11 pwMS undergoing 7 weeks of MSB-Fit, corresponding to what was offered in the present study. The estimate (α = 0.05; power = 0.90; control mean post intervention 7.16±1.18 s; MSB-Fit mean post intervention 6.27±1.18 s; dropout rate = 15%) suggested that a total of n=88 pwMS should be enrolled in the present study.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | This group will be offered 2 weekly sessions (45-60 min) of MS Ballroom Fitness for a period of 7 weeks. All other 'usual care' are allowed. |
|
| Control | No Intervention | This group will continue their habitual living, also including whatever 'usual care' they participate in. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MS Ballroom Fitness | Behavioral | A personalized dance-based concept focusing on balance, walking capacity, and well-being. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Six spot step test (SSST) | Objective test that measures walking coordination and balance. Unit: seconds. | Change from Baseline to 7 weeks |
| WHO5 wellbeing index | Questionnaire that measures current mental well-being. Unit: score (0-100; 100 is better). | Change from Baseline to 7 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Static balance | Objective test that measures static balance (total score based on 2 different tests; 20s right leg foot stand, 20s left leg foot stand). Unit: seconds (0-40s; 40s is better) | Change from Baseline to 7 weeks |
| Functional reach test |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Lars Hvid, PhD | University of Aarhus | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aarhus University, Exercise Biology | Aarhus C | Jutland | 8000 | Denmark |
By Danish Law and following GPDR regulations from Aarhus University, we are not allowed to share individual data.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009103 | Multiple Sclerosis |
| ID | Term |
|---|---|
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| D003711 | Demyelinating Diseases |
Not provided
Not provided
The investigators will use a classic RCT approach, although participants randomized into the control group will be offered the intervention afterwards (hence, termed control-waitlist group).
Not provided
Not provided
Not provided
Objective test that measures how far a person can reach with one arm in standing position. Unit: cm.
| Change from Baseline to 7 weeks |
| Modified functional reach test | Objective test that measures how far a person can reach (forward, left, right) with one arm in sitting position. Unit: cm. NB: This test is used for wheel-chair users only. | Change from Baseline to 7 weeks |
| Four square step test (FSST) | Objective test that measures dynamic stability and co-ordination. Unit: s. | Change from Baseline to 7 weeks |
| 6-minute walk test | Objective test that measures walking endurance. Unit: meters. | Change from Baseline to 7 weeks |
| Trunk Impairment Scale 2.0 | Rater-evaluated test that measures static and dynamic sitting balance as well as co-ordination of trunk movement. Unit: score (0-23; 23 is better). NB: This test is used for wheel-chair users only. | Change from Baseline to 7 weeks |
| Patient determined disease steps | Questionnaire that measures level of disability in multiple sclerosis. Unit: score (0-8; 0 is better). | Change from Baseline to 7 weeks |
| Multiple Sclerosis Walking Scale | Questionnaire that measures walking limitations in multiple sclerosis. Unit: score (0-100; 0 is better). | Change from Baseline to 7 weeks |
| Health-related quality of life visual analogue scale (HR-QoL VAS) | Questionnaire/scale that measures quality of life. Unit: score (0-100; 0 is better). | Change from Baseline to 7 weeks |
| Modified fatigue impact scale | Questionnaire that measures the impact fatigue has on daily life. Unit: score (0-84; 0 is better) | Change from Baseline to 7 weeks |
| Falls-efficacy scale - international | Questionnaire that measures concerns about falling. Unit: score (16-64; 16 is better) | Change from Baseline to 7 weeks |
| Falls | Number of falls in the past year | Change from Baseline to 7 weeks |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |